The trading price of Johnson & Johnson (NYSE:JNJ) floating lower at last check on current market day and closing at $155.88, -0.78% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $155.15 and $156.495. The company’s P/E ratio in the trailing 12-month period was 17.33, while its 5Y monthly beta was 0.41. In examining the 52-week price action we see that the stock hit a 52-week high of $169.99 and a 52-week low of $140.68. Over the past month, the stock has gained 4.19% in value.
Johnson & Johnson, whose market valuation is $375.06 billion at the time of this writing, is expected to release its quarterly earnings report on 2025-Apr-14. The dividend yield on the company stock is 3.22%, while its Forward Dividend ratio is 5.02. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by 2.68 per share this quarter, however they have predicted annual earnings per share of 10.61 for current year and 11.09 for next year.
Analysts have forecast the company to bring in revenue of 22.85B for the current quarter, with the likely lows of 22.51B and highs of 23.09B. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 91.3B.
On the technical side, indicators suggest JNJ has a Hold on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently Hold.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned JNJ a recommendation rating is 19. Out of them, 8 rate it a Hold, while 11 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Johnson & Johnson (JNJ) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
If we dig deeper into the stock’s outlook, we see that the stock’s PEG is 2.94, which symbolizes a positive outlook. A quick review shows that JNJ’s price is currently 0.97% off the SMA20 and 1.27% off the SMA50. The RSI metric on the 14-day chart is currently showing 53.98, and weekly volatility stands at 0.76%. When measured over the past 30 days, the indicator reaches 0.63%. Johnson & Johnson (NYSE:JNJ)’s beta value is currently sitting at 0.41, while the Average True Range indicator is currently displaying 2.24. With analysts defining $162-$166 as the low and high price targets, we arrive at a consensus price target of $164 for the trailing 12-month period. The current price is about -3.93% off the estimated low and -6.49% off the forecast high, based on this estimate. Investors will be thrilled if JNJ’s share price rises to $164, which is the median consensus price. At that level, JNJ’s share price would be -5.21% below current price.
To see how Johnson & Johnson stock has been performing today in comparison to its peers in the industry, here are the numbers: JNJ stock’s performance was -0.78% at last check in today’s session, and 7.20% in the past year. Johnson & Johnson has a P/E ratio of 17.33.
An evaluation of the daily trading volume of Johnson & Johnson (NYSE:JNJ) indicates that the 3-month average is 8.97 million. However, this figure has increased over the past 10 days to an average of 6.43.
Currently, records show that 2.41 billion of the company’s shares remain outstanding. The insiders hold 0.14% of outstanding shares, whereas institutions hold 73.52%. The stats also highlight that short interest as of 2025-05-30, stood at 19.22 million shares, resulting in a short ratio of 2.3 at that time. From this, we can conclude that short interest is 80.00 of the company’s total outstanding shares. It is noteworthy that short shares in May were down slightly from the previous month’s figure, which was 19.68 million. However, since the stock’s price has seen 7.79% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
